Alxn1920 placebo product, ALXN1920
ALXN1920-PMN-201
Phase 2 small_molecule active
Quick answer
Alxn1920 placebo product, ALXN1920 for Primary Mebranous Nephropathy (PMN) is a Phase 2 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Primary Mebranous Nephropathy (PMN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active